Tragara Pharmaceuticals, Inc. is a pharmaceutical company based in San Diego, California focused on the clinical and commercial development of proprietary drugs for the treatment of various cancers. Tragara launched operations in January 2007 and is focusing its development resources on two proprietary compounds: (1) CapoxigemÂ® (apricoxib; TG01), an oral, potent, and selective inhibitor of cyclooxygenase-2 (COX-2) for the treatment of solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer and (2) TG02- multikinase inhibitor for the treatment of hematologic and solid tumors.
Board Members and Advisors (4)Update
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on...
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
vehicles and automotive components
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides...
10955 Vista Sorrento Parkway, Suite 120
San Diego, CA 92130